NASDAQ:FATE | EBITDA | FATE THERAPEUTICS INC

Complete source-backed ebitda history.

Available history
2011-12-31 to 2026-03-31
Data captured

Historical EBITDA

DateEBITDA
2026-03-31-$30.08M
2025-12-31-$31.66M
2025-03-31-$37.95M
2024-12-31-$56.94M
2024-03-31-$46.25M
2023-12-31-$43.19M
2023-03-31-$24.4M
2022-12-31-$59.58M
2022-03-31-$71.71M
2021-12-31-$67.18M
2021-03-31-$45.25M
2020-12-31-$32.54M
2020-03-31-$33.79M
2019-12-31-$28.46M
2019-03-31-$20.01M
2018-12-31-$16.41M
2018-03-31-$13.77M
2017-12-31-$11.95M
2017-03-31-$9.77M
2016-12-31-$7.45M
2016-03-31-$7.69M
2015-12-31-$6.7M
2015-03-31-$7.2M
2014-12-31-$5.82M
2014-03-31-$6.81M
2013-12-31-$4.77M
2013-03-31-$3.2M
2012-12-31-$3.88M

Annual EBITDA

DateEBITDA
2025-12-31-$134.8M
2024-12-31-$191.31M
2023-12-31-$172.23M
2022-12-31-$294.63M
2021-12-31-$211.14M
2020-12-31-$125M
2019-12-31-$98.53M
2018-12-31-$65.89M
2017-12-31-$41.15M
2016-12-31-$31.08M
2015-12-31-$27.1M
2014-12-31-$24.41M
2013-12-31-$17.1M
2012-12-31-$12.97M
2011-12-31-$12.62M